Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Unveiling potential drug targets for hyperparathyroidism through genetic insights via Mendelian randomization and colocalization analyses

Submitted by Frida Mäkelä on Tue, 03/19/2024 - 15:15
  • Read more about Unveiling potential drug targets for hyperparathyroidism through genetic insights via Mendelian randomization and colocalization analyses

Gastroesophageal reflux disease and the risk of respiratory diseases: a Mendelian randomization study

Submitted by Frida Mäkelä on Tue, 03/19/2024 - 11:00
  • Read more about Gastroesophageal reflux disease and the risk of respiratory diseases: a Mendelian randomization study

Metabolic syndrome and risk of colorectal cancer: A Mendelian randomization study

Submitted by Frida Mäkelä on Tue, 03/19/2024 - 10:55
  • Read more about Metabolic syndrome and risk of colorectal cancer: A Mendelian randomization study

Assessing the causal associations of sleep apnea with mental health and socioeconomic status: a bidirectional two-sample Mendelian randomization

Submitted by Frida Mäkelä on Tue, 03/19/2024 - 10:52
  • Read more about Assessing the causal associations of sleep apnea with mental health and socioeconomic status: a bidirectional two-sample Mendelian randomization

A Mendelian randomization study on the causal relationship between smoking, alcohol consumption, and the development of myopia and astigmatism

Submitted by Frida Mäkelä on Tue, 03/19/2024 - 10:47
  • Read more about A Mendelian randomization study on the causal relationship between smoking, alcohol consumption, and the development of myopia and astigmatism

The role of mitochondrial DNA copy number in cardiometabolic disease: a bidirectional two-sample mendelian randomization study

Submitted by Frida Mäkelä on Tue, 03/19/2024 - 10:40
  • Read more about The role of mitochondrial DNA copy number in cardiometabolic disease: a bidirectional two-sample mendelian randomization study

Revisiting an old relationship: the causal associations of the ApoB/ApoA1 ratio with cardiometabolic diseases and relative risk factors-a mendelian randomization analysis

Submitted by Frida Mäkelä on Tue, 03/19/2024 - 10:36
  • Read more about Revisiting an old relationship: the causal associations of the ApoB/ApoA1 ratio with cardiometabolic diseases and relative risk factors-a mendelian randomization analysis

Application and discoveries of metabolomics and proteomics in the study of female infertility

Submitted by Frida Mäkelä on Tue, 03/19/2024 - 10:32
  • Read more about Application and discoveries of metabolomics and proteomics in the study of female infertility

Genetic evidence of the causal relationship between chronic liver diseases and musculoskeletal disorders

Submitted by Frida Mäkelä on Tue, 03/19/2024 - 10:30
  • Read more about Genetic evidence of the causal relationship between chronic liver diseases and musculoskeletal disorders

The Role of the Gut Microbiome and Microbial Dysbiosis in Common Skin Diseases

Submitted by Frida Mäkelä on Tue, 03/19/2024 - 10:13
  • Read more about The Role of the Gut Microbiome and Microbial Dysbiosis in Common Skin Diseases

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 293
  • Page 294
  • Page 295
  • Page 296
  • Current page 297
  • Page 298
  • Page 299
  • Page 300
  • Page 301
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement